Literature DB >> 26280892

Pregnancy Outcome in Patients with Common Variable Immunodeficiency.

Pavlina Kralickova1, Barbora Kurecova2, Ctirad Andrys1, Irena Krcmova1, Dalibor Jilek3, Marcela Vlkova4,5, Jiri Litzman6,7.   

Abstract

PURPOSE: The aim of our retrospective study was to clarify fertility, pregnancy complications and outcomes in common variable immunodeficiency (CVID) females.
METHODS: Retrospective data were obtained from three Czech referral centres. The data were compared with data obtained from the Czech National Registry of Reproduction Health.
RESULTS: Our cohort of patients comprised 54 women with 115 pregnancies; 88 pregnancies in 50 females were finished with live births (77 %). In only 8 women (15%) was the diagnosis of CVID established before the first pregnancy. Replacement immunoglobulin therapy was performed in 10 patients without any moderate or severe adverse effects. Compared with the Czech population, the CVID patients suffered significantly more frequently from the threat of preterm labour (p < 0.0001), vaginal bleeding (p = 0.0001), eclampsia/preeclampsia (p = 0.009) and a higher number of stillbirths (p < 0.0001). Furthermore, the frequency of babies with low birth weight (less than 2500 g) born to the CVID patients was increased compared with the normal population (p < 0.0001). Serum IgG, IgA and IgM determination was done in 57 children of 50 mothers showing 13 cases of IgA deficiency (23%). There was no significant difference among the non-symptomatic, symptomatic untreated and symptomatic treated females in any of the determined gynaecological complications. The number of unsuccessful pregnancies was higher in the symptomatic untreated women.
CONCLUSIONS: Fertility in CVID patients is not decreased, and their pregnancies could be considered more risky compared with those of the general population.

Entities:  

Keywords:  CVID; fertility; pregnancy; replacement therapy

Mesh:

Substances:

Year:  2015        PMID: 26280892     DOI: 10.1007/s10875-015-0188-7

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  25 in total

1.  Evolution of maternofetal transport of immunoglobulins during human pregnancy.

Authors:  A Malek; R Sager; P Kuhn; K H Nicolaides; H Schneider
Journal:  Am J Reprod Immunol       Date:  1996-11       Impact factor: 3.886

2.  Discordant expression of a new WT1 gene mutation in a family with monozygotic twins presenting with congenital nephrotic syndrome.

Authors:  Filip Fencl; Michal Malina; Veronika Stará; Jakub Zieg; Dana Mixová; Tomáš Seeman; Květa Bláhová
Journal:  Eur J Pediatr       Date:  2011-05-26       Impact factor: 3.183

3.  Immunological maturation in an infant of an agammaglobulinaemic mother.

Authors:  N H Holland; P Holland
Journal:  Lancet       Date:  1966-11-26       Impact factor: 79.321

Review 4.  Common variable hypogammaglobulinemia in pregnancy.

Authors:  E Shalev; M Ben-Ami; D Peleg
Journal:  Br J Obstet Gynaecol       Date:  1993-12

5.  The placental transfer of IgG subclasses in human pregnancy.

Authors:  R W Pitcher-Wilmott; P Hindocha; C B Wood
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

6.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

7.  Use of intravenous immune globulin in pregnant women with common variable hypogammaglobulinemia.

Authors:  R U Sorensen; J W Tomford; M T Gyves; N E Judge; S H Polmar
Journal:  Am J Med       Date:  1984-03-30       Impact factor: 4.965

8.  Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration.

Authors:  Maria Giovanna Danieli; Romina Moretti; Lucia Pettinari; Simona Gambini
Journal:  BMJ Case Rep       Date:  2012-12-17

9.  High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy.

Authors:  M Berger; T R Cupps; A S Fauci
Journal:  JAMA       Date:  1982-05-28       Impact factor: 56.272

10.  Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency.

Authors:  Isabella Quinti; Annarosa Soresina; Giuseppe Spadaro; Silvana Martino; Simona Donnanno; Carlo Agostini; Pignata Claudio; Dammacco Franco; Anna Maria Pesce; Federica Borghese; Andrea Guerra; Roberto Rondelli; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2007-02-14       Impact factor: 8.542

View more
  1 in total

1.  Case Report: Post-Partum Complications of NFκB1 Deficiency Underscore a Need to Better Understand Primary Immunodeficiency Management During Pregnancy.

Authors:  Diem-Tran I Nguyen; Amanda Grimes; Donald Mahoney; Sebastian Faro; William T Shearer; Aaron L Miller; Nicholas L Rider
Journal:  Front Pediatr       Date:  2021-07-07       Impact factor: 3.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.